Related Experiment Video
Updated: Jul 22, 2026

04:45
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
Management of oromandibular cancers
Mamoon Rashid1, Tahir Ahmad, Saad Ur Rehman Sarwar
1Department of Plastic and Reconstructive Surgery, Combined Military Hospital, Rawalpindi. mamoon@isb.comsats.net.pk
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|February 7, 2004
Summary
A multidisciplinary approach is crucial for managing oral cavity cancers involving the mandible. This study highlights the importance of collaborative care for improved patient outcomes in these debilitating malignancies.
Area of Science:
- Oncology
- Surgical Oncology
- Head and Neck Surgery
Background:
- Oral cavity cancers involving the mandible present complex management challenges.
- Effective treatment requires a coordinated effort across multiple surgical and oncological specialties.
Purpose of the Study:
- To underscore the significance of a multidisciplinary approach in treating oromandibular tumors.
- To evaluate the outcomes of integrated cancer care for mandible-involved oral cancers.
Main Methods:
- A descriptive study of 63 patients with biopsy-proven oromandibular tumors over six years.
- Inclusion criteria: malignant oral cavity tumors involving the mandible requiring resection and reconstruction.
- Methods involved histopathological assessment, surgical resection, various flap reconstructions, and adjuvant radiotherapy.
Main Results:
- Tumor-free resection margins achieved in 56 patients; 88% were Squamous cell carcinoma.
- Various free and myocutaneous flaps were used for reconstruction with low flap loss rates (1 total, 3 partial).
- One-year follow-up showed functional improvements in speech (37/56) and diet (15/56), with 33/56 achieving satisfactory contour restoration.
Conclusions:
- Multidisciplinary collaboration is essential for managing oral cavity cancers involving the mandible.
- Integrated care pathways lead to better functional and aesthetic outcomes.
- Effective management reduces morbidity and improves patient survival in these challenging cases.
More Related Videos
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.

